Skip to main content

Bromo-DragonFLY Contents History Pharmacology Dosage Toxicity Drug prohibition laws See also Notes References Navigation menu502759-67-3Interactive imageInteractive imageChEMBL14902480147768719838867208998390571054444710496688verify"Bromo-DragonFLY"the original"Erowid Bromo-Dragonfly Vault"Archived"Erowid Bromo-DragonFly Vault : Dosage"Archived10.1021/jm980352598570842159207010.1016/j.toxlet.2018.07.01830036687"Erowid Bromo-Dragonfly Vault : Reported GHB-Related Death Involved Bromo-Dragonfly"Archived"Erowid Bromo-Dragonfly Vault : Information about a death reportedly related to Bromo-Dragonfly"Archived"Man i 20-årsåldern dog av drogen Dragonfly"the original"Nyt stof har slået dansker ihjel"the original10.1016/j.forsciint.2008.11.00119091499"Kassisurman päätekijälle 11,5 vuoden vankeustuomio taposta""Erowid 2C-B-Fly Vault: Death Report"ArchivedBromo-dragonfly – livsfarlig missbruksdrogArchived18522262"England | Surrey | 'I nearly died from taking £5 hit'"Archived"Delayed onset of seizures and toxicity associated with recreational use of Bromo-dragonFLY"10.1007/bf03178273355040319876858"| Danish man died after trip on Chinese drug"Archived"Second Victim Dies After Taking Designer Drug In Konawa"Archived"'I nearly died from taking £5 hit'"Archived"Bromo-Dragonfly Report"Archived"Ask Erowid : ID 3103 : Does Bromo-Dragonfly fall under the UK ban on phenethylamines?"Archived"Consideration of the Novel Psychoactive Substances ('Legal Highs')"Archived"UK Misuse of Drugs Act 1971 > 1971 c. 38 > SCHEDULE 2"Archived"Archived copy"Archived"Archived copy"Archived"Amendment of Executive Order on Euphoriant Substances"Archived"Erowid Bromo-Dragonfly Vault : Legal Status"Archived"List of narcotic drugs according to Norwegian law"Archived"Statens Legemiddelverk about derivates and Bromo-DragonFLY"the original"Modified Romanian law 143/2000 on January 10, 2010"the original"Queensland Drugs Misuse Regulation 1987"Archived"Archived copy"ArchivedDesign drugs'A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor'10.1021/jm000491yBromo-dragonfly – livsfarlig missbruksdrogPer, 35, blev stympad av dödsdrogen - Vårdades i respirator i tio dygn efter att ha tagit Bromo-Dragonflyeee

2C-B-FLY2CBFly-NBOMe5-MeO-BFE5-MeO-DiBFBromo-DragonFLYF-2F-22TFMFly1B-LSD1P-ETH-LAD1P-LSD2-Butyllysergamide3-PentyllysergamideAL-LADALD-52BU-LADDiallyllysergamideDimethyllysergamideECPLAErgometrineETH-LADIP-LADLAE-32LAMPALPD-824LSALSDLSD-PipLSHLSM-775LSZMethylergometrineMIPLAMethysergideMLD-41PARGY-LADPRO-LAD2C-B2C-B-AN2C-Bn2C-Bu2C-C2C-CN2C-CP2C-D2C-E2C-EF2C-F2C-G2C-G-12C-G-22C-G-32C-G-42C-G-52C-G-62C-G-N2C-H2C-I2C-iP2C-N2C-NH22C-O2C-O-42C-P2C-Ph2C-SE2C-T2C-T-22C-T-32C-T-42C-T-52C-T-62C-T-72C-T-82C-T-92C-T-102C-T-112C-T-122C-T-132C-T-142C-T-152C-T-162C-T-172C-T-182C-T-192C-T-202C-T-212C-T-222C-T-22.52C-T-232C-T-242C-T-252C-T-272C-T-282C-T-302C-T-312C-T-322C-T-332C-TFE2C-TFM2C-YN2C-V25B-NB3OMe25C-NB3OMe25D-NB3OMe25E-NB3OMe25H-NB3OMe25I-NB3OMe25N-NB3OMe25P-NB3OMe25T2-NB3OMe25T4-NB3OMe25T7-NB3OMe25TFM-NB3OMe25B-NB4OMe25C-NB4OMe25D-NB4OMe25E-NB4OMe25H-NB4OMe25I-NB4OMe25N-NB4OMe25P-NB4OMe25T2-NB4OMe25T4-NB4OMe25T7-NB4OMe25TFM-NB4OMe25B-NBF25C-NBF25D-NBF25E-NBF25H-NBF25I-NBF25P-NBF25T2-NBF25T7-NBF25TFM-NBF25B-NBMD25C-NBMD25D-NBMD25E-NBMD25F-NBMD25H-NBMD25I-NBMD25P-NBMD25T2-NBMD25T7-NBMD25TFM-NBMD25B-NBOH25C-NBOH25CN-NBOH25D-NBOH25E-NBOH25F-NBOH25H-NBOH25I-NBOH25P-NBOH25T2-NBOH25T7-NBOH25TFM-NBOH25B-NBOMe25C-NBOMe25CN-NBOMe25D-NBOMe25E-NBOMe25F-NBOMe25G-NBOMe25H-NBOMe25I-NBOMe25iP-NBOMe25N-NBOMe25P-NBOMe25T2-NBOMe25T4-NBOMe25T7-NBOMe25TFM-NBOMe25I-NB34MD2CBCB-NBOMe2CBFly-NBOMeNBOMe-mescaline3C-AL3C-BZ3C-DFE3C-E3C-P4C-B4C-D4C-T-2DOTDOBDOCDOEFDOETDOFDOIDOiPRDOMDONDOPRDOTFMMEMHOT-2HOT-7HOT-17DMMDADMMDA-2LophophineMDAMMDAMMDA-2MMDA-3aMMDMA2-Bromomescaline3-TE4-TE3-TM4-TMAllylescalineAsymbescalineBuscalineCyclopropylmescalineDifluoromescalineDifluoroescalineEscalineFluoroproscalineIsobuscalineIsoproscalineJimscalineMescalineMetaescalineMethallylescalineProscalineThioproscalineTrifluoroescalineTrifluoromescaline2C-B-BUTTERFLY2C-B-DragonFLY2CB-5-hemifly2-TOM5-TOET5-TOM2CB-Ind2CD-5EtOBOBBODβk-2C-Bβk-2C-IDESOXYDMCPADMBMPPDOB-FLYFenfluramineGaneshaMacromerineMMATCB-2TOMSOBZPpFPP4,5-DHP-α-MT5-MeO-α-ET5-MeO-α-MTα-ETα-MT(Daltocin) 4-HO-DALT(Daltacetin) 4-AcO-DALT5-MeO-DALTDALT(Ethacetin) 4-AcO-DET(Ethocin) 4-HO-DET5-MeO-DET(T-9) DET(Ethocybin) 4-PO-DET(Ipracetin) 4-AcO-DiPT(Iprocin) 4-HO-DiPT5-MeO-DiPTDiPT4,5-DHP-DMT2,N,N-TMT4-AcO-DMT4-HO-5-MeO-DMT4,N,N-TMT4-Propionyloxy-DMT5,6-diBr-DMT5-AcO-DMT5-Bromo-DMT5-MeO-2,N,N-TMT5-MeO-4,N,N-TMT5-MeO-α,N,N-TMT5-MeO-DMT5-N,N-TMT7,N,N-TMTα,N,N-TMT(Bufotenin) 5-HO-DMTDMTNorbaeocystin(Psilocin) 4-HO-DMT(Psilocybin) 4-PO-DMT(Depracetin) 4-AcO-DPT(Deprocin) 4-HO-DPT5-MeO-DPT(The Light) DPT18-MAC18-MCCoronaridineIbogaineIbogamineME-18-MCNoribogaineTabernanthineVoacangine(Metocin) 4-HO-MET(Metocetin) 4-AcO-MET5-MeO-METMET(Mipracetin) 4-AcO-MiPT(Miprocin) 4-HO-MiPT5-Me-MiPT(Moxy) 5-MeO-MiPTMiPT4-HO-DBT4-HO-EPT4-HO-McPT(Lucigenol) 4-HO-MPMI(Meprocin) 4-HO-MPT5-MeO-EiPT5-MeO-MALT5-MeO-MPMIAeruginascinBaeocystinDBTDCPTEiPTEPTMPTPiPTAL-38022AALPHADimemebfeEfavirenzLorcaserinM-ALPHARH-34empathogens5-APB5-MAPB6-APBsubstituted benzofuransMDAIMDMA2-FluorodeschloroketamineArketamineDeschloroketamineEthketamineEsketamineKetamineMethoxetamineMethoxmetamineMethoxyketamineNorketamineTiletamine3'-HO-PCP3'-MeO-PCE3'-MeO-PCMo3'-MeO-PCPBDPCDieticyclidineEticyclidineMethoxydinePCPrPhencyclidineRolicyclidineTenocyclidineBTCPGacyclidinePRE-084DiphenidineEphenidineFluorolintaneMethoxphenidineDextrallorphanDextromethorphanDextrorphanRacemethorphanRacemorphan2-EMSB2-MDP8A-PDHQAptiganelBudipineDelucemineDexoxadrolDizocilpineEtoxadrolHerkinorinIbogaineMidafotelNEFANeramexaneNitrous oxideNoribogainePerzinfotelRB-64RemacemideSalvinorin ASelfotelXenonAtropineBenactyzineBenzatropineBenzydamineBiperidenBRN-1484501BrompheniramineBZCAR-226,086CAR-301,060CAR-302,196CAR-302,282CAR-302,368CAR-302,537CAR-302,668ChloropyramineChlorphenamineClemastineCS-27349CyclizineCyproheptadineDicycloverineDimenhydrinateDiphenhydramineDitranDoxylamineEA-3167EA-3443EA-3580EA-3834ElemicinFlavoxateHyoscyamineJB-318JB-336MeclozineMepyramineMyristicinOrphenadrineOxybutyninPheniraminePhenyltoloxamineProcyclidinePromethazineScopolamineTolterodineTrihexyphenidylTripelennamineTriprolidineWIN-2299THC (Dronabinol)THCVAM-087AM-251AM-279AM-281AM-356AM-374AM-381AM-404AM-411AM-630AM-661AM-678AM-679AM-694AM-735AM-855AM-881AM-883AM-905AM-906AM-919AM-926AM-938AM-1116AM-1172AM-1220AM-1221AM-1235AM-1241AM-1248AM-1710AM-1714AM-1902AM-2201AM-2212AM-2213AM-2232AM-2233AM-2389AM-3102AM-4030AM-4054AM-4056AM-4113AM-6545CP 47,497CP 55,244CP 55,940(±)-CP 55,940(+)-CP 55,940(-)-CP 55,940HU-210HU-211HU-239HU-243HU-308HU-320HU-331HU-336HU-345JWH-007JWH-015JWH-018JWH-019JWH-030JWH-047JWH-048JWH-051JWH-057JWH-073JWH-081JWH-098JWH-116JWH-120JWH-122JWH-133JWH-139JWH-147JWH-148JWH-149JWH-149JWH-161JWH-164JWH-166JWH-167JWH-171JWH-175JWH-176JWH-181JWH-182JWH-184JWH-185JWH-192JWH-193JWH-193JWH-194JWH-195JWH-196JWH-197JWH-198JWH-199JWH-200JWH-203JWH-205JWH-210JWH-210JWH-213JWH-220JWH-229JWH-234JWH-249JWH-250JWH-251JWH-253JWH-258JWH-300JWH-302JWH-307JWH-336JWH-350JWH-359JWH-387JWH-398JWH-4244-HTMPIPO5F-AB-FUPPYCA5F-AB-PINACA5F-ADB5F-ADB-PINACA5F-ADBICA5F-AMB5F-APINACA5F-CUMYL-PINACA5F-NNE15F-PB-225F-SDB-006A-796,260A-836,339AB-001AB-005AB-CHFUPYCAAB-CHMINACAAB-FUBINACAAB-PINACAADAMANTYL-THPINACAADB-CHMINACAADB-FUBINACAADB-PINACAADBICAADSB-FUB-187AMB-FUBINACAAPICAAPINACAAPP-FUBINACACB-13CUMYL-PICACUMYL-PINACACUMYL-THPINACADMHPEAM-2201FAB-144FDU-PB-22FUB-144FUB-APINACAFUB-JWH-018FUB-PB-22FUBIMINAJTE 7-31JTE-907LevonantradolMDMB-CHMICAMDMB-CHMINACAMDMB-FUBINACAMEPIRAPIMMAM-2201MDA-19MN-18MN-25NESS-0327NESS-040C5NabiloneNabitanNM-2201NNE1Org 28611ParahexylPTI-1PTI-2PX-1PX-2PX-3QUCHICQUPICRCS-4RCS-8SDB-005SDB-006STS-135THC-O-acetateTHC-O-phosphateTHJ-018THJ-2201UR-144WIN 55,212-2XLR-11ApomorphineAporphineBromocriptineCabergolineLisurideMemantineNuciferinePergolidePhenethylaminePiribedilPramipexoleRopiniroleRotigotineSalvinorin Adopamine reuptake inhibitorscocainemethylphenidatereleasing agentsamphetaminemethamphetamineprecursorslevodopaCI-966EszopicloneIbotenic acidMuscimolAmanita muscariaZaleplonZolpidemZopicloneAliphatic hydrocarbonsButaneGasolineKerosenePropaneAromatic hydrocarbonsTolueneEthersDiethyl etherEnfluraneHaloalkanesChlorofluorocarbonsChloroform2-EMSBAlazocineBremazocineButorphanButorphanolCyclazocineCyclorphanCyprenorphineDiprenorphineEnadolineHerkinorinHeroinHZ-2IbogaineKetazocineLevallorphanLevomethorphanLevorphanolLPK-26MetazocineMorphineNalbuphineNalmefeneNalorphineNoribogaineOxilorphanPentazocinePhenazocineProxorphanRacemethorphanRacemorphanSalvinorin ASpiradolineTifluadomU-50488U-69,593XorphanolGlaucineIsoaminileNoscapinePukateine25B-NBOMe25C-NBOMe25D-NBOMe25I-NBOMe25N-NBOMe2C-B2C-B-AN2C-Bn2C-Bu2C-C2C-CN2C-CP2C-D2C-E2C-EF2C-F2C-G2C-G-12C-G-22C-G-32C-G-42C-G-52C-G-62C-G-N2C-H2C-I2C-iP2C-N2C-NH22C-O2C-O-42C-P2C-Ph2C-SE2C-T2C-T-22C-T-32C-T-42C-T-52C-T-62C-T-72C-T-82C-T-92C-T-102C-T-112C-T-122C-T-132C-T-142C-T-152C-T-162C-T-172C-T-182C-T-192C-T-202C-T-212C-T-222C-T-22.52C-T-232C-T-242C-T-252C-T-272C-T-282C-T-302C-T-312C-T-322C-T-332C-TFE2C-TFM2C-YN2C-VAllylescalineDESOXYEscalineIsoproscalineJimscalineMacromerineMEPEAMescalineMetaescalineMethallylescalineProscalinePsi-2C-T-4TCB-2PhenylethanolamineHordeninePhenethylamineα-Methylphenethylamineβ-Methylphenethylaminem-MethylphenethylamineN-Methylphenethylamineo-Methylphenethylaminep-MethylphenethylamineMethylphenidateLophophineMDPEAMDMPEABOHDMPEAChlorphentermineCloforexClortermineEtolorexMephenterminePentorexPhentermineMDPHMDMPHCericlamine4-CAB4-MABAriadneBDBButyloneEBDBEutyloneMBDBPhenylisobutylamine6-FNE6-OHDAa-Me-DAa-Me-TRAAdrenochromeCiladopaD -DOPADimetofrineDopamineEpinephrineEpinineEtilefrineEthylnorepinephrineFenclonineIbopamineIsoprenalineIsoetarineL -DOPAL -DOPSL -PhenylalanineL -Tyrosinem-TyramineMetanephrineMetaraminolMetaterolMetirosineMethyldopaN,N-DimethyldopamineNordefrinLevonordefrinNorepinephrineNorfenefrineNormetanephrineOrciprenalinep-Octopaminep-TyraminePhenylephrineSynephrine


Psychedelic phenethylaminesEntheogensSerotonin receptor agonistsBromoarenesDesigner drugs


psychedelic drugphenethylamineLSDμgstereocenterstereoisomerDavid E. Nicholsdihydrofuranagonist5-HT2Aserotonin receptorbindingaffinityserotoninreceptorsLSDblotterstherapeutic rangeNorwaySweden2C-B-FLYVasoconstrictivenecrosisgangrenetolazolinedisturbing experiencesasphyxiaSeizures2C-ESchedule Ihttp://www.gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors73-eng.phpPsychoactive Substances Act 2016Sveriges riksdagMedical Products AgencySveriges riksdagsStatens folkhälsoinstitutLagen om förbud mot vissa hälsofarliga varorJakob Axel Nielsen












Bromo-DragonFLY




From Wikipedia, the free encyclopedia






Jump to navigation
Jump to search





















Bromo-DragonFLY

Kekulé, skeletal formula of bromo-DragonFLY (R)
(R)-(−)-bromo-DragonFLY

Names

IUPAC name
1-(4-Bromofuro[2,3-f] [1]benzofuran-8-yl)propan-2-amine[1]

Other names
Bromo-benzodifuranyl-isopropylamine[citation needed]

Identifiers

CAS Number



  • 502759-67-3 ☒N


3D model (JSmol)


  • Interactive image

  • Interactive image



ChEMBL


  • ChEMBL149024 ☒N


ChemSpider


  • 8014776 ☒N


  • 8719838 R ☒N


  • 8672089 S ☒N




PubChem CID


  • 9839057


  • 10544447 R


  • 10496688 S






Properties

Chemical formula


C
13
H
12
BrNO
2


Molar mass
294.144 g mol−1

log P
2.519

Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).


☒N verify (what is ☑Y☒N ?)

Infobox references


Bromo-DragonFLY (or 3C-Bromo-Dragonfly, DOB-Dragonfly[2]) is a psychedelic drug related to the phenethylamine family. Bromo-DragonFLY is considered a potent hallucinogen, having around one third the potency of LSD with a normal dose in the region of 200 μg to 800 μg,[citation needed] and it has an extremely long duration of action, up to several days.[3] Bromo-DragonFLY has a stereocenter and (R)-(−)-bromo-DragonFLY is the more active stereoisomer.




Contents





  • 1 History


  • 2 Pharmacology


  • 3 Dosage


  • 4 Toxicity


  • 5 Drug prohibition laws

    • 5.1 United States


    • 5.2 Canada


    • 5.3 United Kingdom


    • 5.4 Sweden


    • 5.5 Denmark


    • 5.6 Norway


    • 5.7 Poland


    • 5.8 Romania


    • 5.9 Australia


    • 5.10 Finland



  • 6 See also


  • 7 Notes


  • 8 References




History


Bromo-DragonFLY was first synthesized by Matthew Parker in the laboratory of David E. Nichols in 1998. As with the earlier and less potent dihydrofuran series of compounds nicknamed FLY, Bromo-DragonFLY was named after its superficial structural resemblance to a dragonfly.



Pharmacology


The hallucinogenic effect of bromo-DragonFLY is mediated by its agonist activity at the 5-HT2A serotonin receptor. Bromo-DragonFLY also has a high binding affinity for the 5-HT2B and 5-HT2Cserotonin receptors, and is most accurately described as a non-subtype selective 5-HT2 agonist, as it is actually twice as potent an agonist for 5-HT2C receptors as for 5-HT2A, as well as being less than 5x selective for 5-HT2A over 5-HT2B.[4][5] Bromo-DragonFLY is also a MAO-A inhibitor,[6] and thus strongly inhibits oxidative deamination of 5-HT, increasing its risk profile.



Dosage


The typical dose of Bromo-DragonFLY is not known, however it has varied from 500 μg to 1 mg.[3] It has about 300 times the potency of mescaline, or 1/3 the potency of LSD. It has been sold in the form of blotters, similar to the distribution method of LSD, which has led to confusion, and reports of mistakenly consuming Bromo-DragonFly. It has a much longer duration of action than LSD and can last for up to 2–3 days[3] following a single large dose, with a slow onset of action that can take up to 6 hours before the effects are felt.



Toxicity




4BDF powder. The pink color is most likely due to an impurity. The color of pure BDF is usually white to off-white, similar to most recreational drugs, so there is no way to distinguish between them by eye.[citation needed]


The toxicity of Bromo-DragonFLY appears to be fairly high for humans when taken in doses significantly above the therapeutic range, with reports of at least five deaths believed to have resulted from Bromo-DragonFLY reported in Norway,[7]Sweden,[8][9]
Denmark,[10][11]
Finland[12]
and the United States.
Laboratory testing has confirmed that in October 2009, a batch of Bromo-Dragonfly was distributed, mislabeled as the related compound 2C-B-FLY, which is around 20x less potent than BDF by weight. This mistake is believed to have contributed to several lethal overdoses and additional hospitalizations. The batch implicated in these deaths also contained significant synthesis impurities, which may have contributed to the toxicity.[13]


Vasoconstrictive action resulting from severe overdose of Bromo-DragonFLY is known to have caused tissue necrosis of the extremities in at least one case. In September 2007, a 35-year-old Swedish male required amputation of the front part of his feet and several fingers on one hand after taking a massive (but unknown) overdose; reportedly, the compound acted as a long-acting efficacious vasoconstrictor, leading to necrosis and gangrene which became apparent several weeks after the overdose occurred. Treatment was of limited efficacy in this case, although tolazoline is reportedly an effective treatment where available.[14][15]


Overdose-associated disturbing experiences and health problems have been described. One case in 2008 in England involved inhalation of vomit, causing nearly fatal asphyxia.[16]Seizures have also been reported.[17]


On October 3, 2009, a 22-year-old male from Copenhagen died after ingesting Bromo-dragonfly. His friend described the trip saying, "It was like being dragged to hell and back again. Many times. It is the most evil [thing] I've ever tried. It lasted an eternity." [18]


On May 7, 2011, in the United States, two young adults died after overdosing on Bromo-DragonFLY, which they thought was 2C-E, and several others were hospitalized during the same incident. Because they took a dosage appropriate for 2C-E, those who took the drug received, in some cases, 100x the normal dose. Both deaths followed seizures, vomiting blood, and terrifying hallucinations. Several surviving victims are reportedly still suffering from its physical effects.[19]



Drug prohibition laws



United States


Bromo-DragonFLY is listed as a Schedule I in Oklahoma.[citation needed]



Canada


Schedule III as of Oct 12 2016. "2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond" to a broad definition that includes anything with a 2,5-dimethoxyphenylethamine core. This includes most 2C-s, DOx, TMA, Aleph, NBOMes, NBOHs, NBF, bk-2-C-B, 2C-B-Fly, Bromo-DragonFLY, etc. See http://www.gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors73-eng.php.



United Kingdom


Bromo-DragonFLY is widely reported by the media as being a class A drug.[20] However, as of 2014, it remains unclear to what extent it is covered by the UK phenylethylamine catch-all clause, with commentators noting both the structural similarities[21] and differences[22] to the phenylethylamine class. If the prosecution could demonstrate structural similarity in court, it would be considered a Class A substance[23] but as a benzodifuran it is significantly different to this class. It is not explicitly named in the misuse of drugs act.[24] It would be covered by the UK Psychoactive Substances Act 2016.



Sweden


Sveriges riksdag added Bromo-Dragonfly to schedule IV ("substances, plant materials and fungi with medical use") as narcotics in Sweden as of Jan 3, 2008, published by Medical Products Agency in their regulation LVFS 2007:14 listed as Bromo-Dragonfly, brombensodifuranyl-isopropylamin.[25] Bromo-DragonFLY was first classified as "health hazard" by Sveriges riksdags health ministry Statens folkhälsoinstitut [sv] under the act Lagen om förbud mot vissa hälsofarliga varor [sv] (translated Act on the Prohibition of Certain Goods Dangerous to Health) as of Jul 15, 2007, in their regulation SFS 2007:600 listed as brombensodifuranylisopropylamin (Bromo-Dragonfly), making it illegal to sell or possess.[26]



Denmark


On December 3, 2007 the drug was banned in Denmark.[27] The substance has been declared illegal by health minister Jakob Axel Nielsen, following recommendations from the Danish Health Ministry. It is currently classified as a dangerous narcotic and therefore its possession, manufacture, importation, supply or usage is strictly prohibited. Anyone involved in such activities can face legal action.[28]



Norway


Bromo-DragonFLY is currently on the Norwegian narcotics list,.[29][30] Thus it is effectively a narcotic drug by Norwegian law.



Poland


Currently, Bromo-DragonFLY is an uncontrolled substance in Poland.[citation needed]



Romania


The chemical compound has been added as an illegal substance under the Law 143/2000 on February 10, 2010.[31]



Australia


As of 9 September 2011, Bromo-DragonFLY was added to Schedule 2 of the Queensland Drugs Misuse Regulation 1987.[32]


Nationally, the drug is listed under Schedule 9 (Prohibited) of the Poisons Standard. Accordingly, the drug is prohibited in all states and territories.[33]



Finland


As of 12 March 2012, Bromo-DragonFLY is an illegal designer drug.[34]



See also


  • 2C-B

  • DOB

  • 2C-B-FLY

  • 5-HT2A receptor

  • PiHKAL


Notes




  1. ^ "Bromo-DragonFLY". Forendex. USA: Southern Association of Forensic Scientists. Archived from the original on 6 October 2014. Retrieved 16 March 2012..mw-parser-output cite.citationfont-style:inherit.mw-parser-output .citation qquotes:"""""""'""'".mw-parser-output .citation .cs1-lock-free abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .citation .cs1-lock-subscription abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registrationcolor:#555.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration spanborder-bottom:1px dotted;cursor:help.mw-parser-output .cs1-ws-icon abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center.mw-parser-output code.cs1-codecolor:inherit;background:inherit;border:inherit;padding:inherit.mw-parser-output .cs1-hidden-errordisplay:none;font-size:100%.mw-parser-output .cs1-visible-errorfont-size:100%.mw-parser-output .cs1-maintdisplay:none;color:#33aa33;margin-left:0.3em.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-formatfont-size:95%.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-leftpadding-left:0.2em.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-rightpadding-right:0.2em


  2. ^ "Erowid Bromo-Dragonfly Vault". www.erowid.org. Archived from the original on 23 March 2018. Retrieved 26 March 2018.


  3. ^ abc "Erowid Bromo-DragonFly Vault : Dosage". Archived from the original on 2008-03-22.


  4. ^ Parker MA, Marona-Lewicka D, Lucaites VL, Nelson DL, Nichols DE (December 1998). "A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor". Journal of Medicinal Chemistry. 41 (26): 5148–9. doi:10.1021/jm9803525. PMID 9857084.


  5. ^ Corazza O, Schifano F, Farre M, Deluca P, Davey Z, Torrens M, Demetrovics Z, Di Furia L, Flesland L, Siemann H, Skutle A, Van Der Kreeft P, Scherbaum N. Designer drugs on the internet: a phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly. Current Clinical Pharmacology. 2011 May;6(2):125-9.
    PMID 21592070



  6. ^ Noble C, Holm NB, Mardal M, Linnet K (1 October 2018). "Bromo-dragonfly, a psychoactive benzodifuran, is resistant to hepatic metabolism and potently inhibits monoamine oxidase A". Toxicology Letters. 295: 397–407. doi:10.1016/j.toxlet.2018.07.018. PMID 30036687.




  7. ^
    Kajsa Hallberg (2007-04-03). "Man i 20-årsåldern dog av drogen Dragonfly". expressen.se (in Swedish). AB Kvällstidningen Expressen. Archived from the original on 2011-10-20. Retrieved 2009-10-30.



  8. ^
    Ritzau (2008-08-24). "Nyt stof har slået dansker ihjel". jp.dk (in Danish). Archived from the original on 2008-09-12. Retrieved 2009-10-30.



  9. ^ Andreasen MF; Telving R; Birkler RI; Schumacher B; Johannsen M. (January 2009). "A fatal poisoning involving Bromo-Dragonfly". Forensic Science International. 183 (1–3): 91–6. doi:10.1016/j.forsciint.2008.11.001. PMID 19091499.


  10. ^
    Siukonen, Timo (2012-12-14). "Kassisurman päätekijälle 11,5 vuoden vankeustuomio taposta". Helsingin Sanomat (in Finnish). Retrieved 2012-12-14.



  11. ^ "Erowid 2C-B-Fly Vault: Death Report". Archived from the original on 2009-10-13.


  12. ^ Bromo-dragonfly – livsfarlig missbruksdrog Archived 2008-12-27 at the Wayback Machine (Swedish)


  13. ^ Thorlacius K, Borna C, Personne M. Bromo-dragon fly--life-threatening drug. Can cause tissue necrosis as demonstrated by the first described case. (Swedish). Lakartidningen. 2008 Apr 16-22;105(16):1199-200.
    PMID 18522262



  14. ^ George, Sallie (2008-03-27). "England | Surrey | 'I nearly died from taking £5 hit'". BBC News. Archived from the original on 2012-04-23. Retrieved 2010-02-08.


  15. ^ Wood DM, Looker JJ, Shaikh L, Button J, Puchnarewicz M, Davies S, Lidder S, Ramsey J, Holt DW, Dargan PI (December 2009). "Delayed onset of seizures and toxicity associated with recreational use of Bromo-dragonFLY". Journal of Medical Toxicology. 5 (4): 226–9. doi:10.1007/bf03178273. PMC 3550403. PMID 19876858.


  16. ^ "| Danish man died after trip on Chinese drug". Jp.dk. Archived from the original on 2012-04-23. Retrieved 2010-02-08.


  17. ^ "Second Victim Dies After Taking Designer Drug In Konawa". newson6.com. Archived from the original on 27 March 2018. Retrieved 26 March 2018.


  18. ^ George, Sallie (2008-03-27). "'I nearly died from taking £5 hit'". BBC News. BBC. Archived from the original on 2012-04-23. Retrieved 2013-11-28.


  19. ^ Psychonaut Webmapping Research Group. "Bromo-Dragonfly Report" (PDF). www.psychonautproject.eu/. Institute of Psychiatry, London. Archived (PDF) from the original on 15 May 2012. Retrieved 12 June 2014.


  20. ^ "Ask Erowid : ID 3103 : Does Bromo-Dragonfly fall under the UK ban on phenethylamines?". www.erowid.org. Archived from the original on 24 March 2018. Retrieved 26 March 2018.


  21. ^ Advisory Council on the Misuse of Drugs. "Consideration of the Novel Psychoactive Substances ('Legal Highs')" (PDF). UK Home Office. Archived (PDF) from the original on 14 July 2014. Retrieved 12 June 2014.


  22. ^ UK Home Office. "UK Misuse of Drugs Act 1971 > 1971 c. 38 > SCHEDULE 2". Archived from the original on 2012-12-29. Retrieved 2013-11-28.


  23. ^ "Archived copy" (PDF). Archived (PDF) from the original on 2013-09-28. Retrieved 2013-09-15.CS1 maint: Archived copy as title (link)


  24. ^ "Archived copy" (PDF). Archived (PDF) from the original on 2013-09-29. Retrieved 2013-09-25.CS1 maint: Archived copy as title (link)


  25. ^ "Amendment of Executive Order on Euphoriant Substances". Danish Medicines Agency. 2007. Archived from the original on 2012-04-23.



  26. ^ "List of narcotic drugs according to Norwegian law". Archived from the original on 2012-04-23.


  27. ^ "Statens Legemiddelverk about derivates and Bromo-DragonFLY". Archived from the original on 2009-05-28.


  28. ^ "Modified Romanian law 143/2000 on January 10, 2010". Archived from the original on June 24, 2010. Retrieved February 28, 2010.


  29. ^ "Queensland Drugs Misuse Regulation 1987" (PDF). Archived (PDF) from the original on 2011-04-22.


  30. ^ Poisons Standard October 2015 "Archived copy". Archived from the original on 2016-01-19. Retrieved 2016-01-06.CS1 maint: Archived copy as title (link)


  31. ^ Design drugs (in Finnish)



References


.mw-parser-output .refbeginfont-size:90%;margin-bottom:0.5em.mw-parser-output .refbegin-hanging-indents>ullist-style-type:none;margin-left:0.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>ddmargin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none.mw-parser-output .refbegin-100font-size:100%


  • 'A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor' J. Med. Chem. 41(26): 5148-5149

  • 'Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT2A/2C receptor agonists' by J. J. Chambers, D. M. Kurrasch-Orbaugh, M. A. Parker, and D. E. Nichols in J. Med. Chem. 44(6): 1003-1010 (2001) doi:10.1021/jm000491y

  • Bromo-dragonfly – livsfarlig missbruksdrog

  • Per, 35, blev stympad av dödsdrogen - Vårdades i respirator i tio dygn efter att ha tagit Bromo-Dragonfly

  • [1]

  • [2]












Retrieved from "https://en.wikipedia.org/w/index.php?title=Bromo-DragonFLY&oldid=893292422"










Navigation menu


























(window.RLQ=window.RLQ||[]).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"1.460","walltime":"1.866","ppvisitednodes":"value":7948,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":649943,"limit":2097152,"templateargumentsize":"value":31477,"limit":2097152,"expansiondepth":"value":22,"limit":40,"expensivefunctioncount":"value":10,"limit":500,"unstrip-depth":"value":1,"limit":20,"unstrip-size":"value":102728,"limit":5000000,"entityaccesscount":"value":3,"limit":400,"timingprofile":["100.00% 1331.108 1 -total"," 43.96% 585.163 1 Template:Chembox"," 38.47% 512.093 1 Template:Reflist"," 25.42% 338.388 1 Template:Chembox_Identifiers"," 19.44% 258.823 29 Template:Navbox"," 15.93% 212.055 3 Template:Chembox_headerbar"," 15.70% 209.034 9 Template:Trim"," 13.61% 181.166 22 Template:Cite_web"," 11.44% 152.263 1 Template:Fi_icon"," 11.13% 148.130 1 Template:Link_language"],"scribunto":"limitreport-timeusage":"value":"0.625","limit":"10.000","limitreport-memusage":"value":14666747,"limit":52428800,"cachereport":"origin":"mw1333","timestamp":"20190513173654","ttl":2592000,"transientcontent":false););"@context":"https://schema.org","@type":"Article","name":"Bromo-DragonFLY","url":"https://en.wikipedia.org/wiki/Bromo-DragonFLY","sameAs":"http://www.wikidata.org/entity/Q2452973","mainEntity":"http://www.wikidata.org/entity/Q2452973","author":"@type":"Organization","name":"Contributors to Wikimedia projects","publisher":"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":"@type":"ImageObject","url":"https://www.wikimedia.org/static/images/wmf-hor-googpub.png","datePublished":"2004-11-06T19:13:56Z","dateModified":"2019-04-20T10:37:25Z","image":"https://upload.wikimedia.org/wikipedia/commons/3/31/R-Bromo-DragonFLY.svg","headline":"chemical compound"(window.RLQ=window.RLQ||[]).push(function()mw.config.set("wgBackendResponseTime":157,"wgHostname":"mw1246"););

Popular posts from this blog

19. јануар Садржај Догађаји Рођења Смрти Празници и дани сећања Види још Референце Мени за навигацијуу

Israel Cuprins Etimologie | Istorie | Geografie | Politică | Demografie | Educație | Economie | Cultură | Note explicative | Note bibliografice | Bibliografie | Legături externe | Meniu de navigaresite web oficialfacebooktweeterGoogle+Instagramcanal YouTubeInstagramtextmodificaremodificarewww.technion.ac.ilnew.huji.ac.ilwww.weizmann.ac.ilwww1.biu.ac.ilenglish.tau.ac.ilwww.haifa.ac.ilin.bgu.ac.ilwww.openu.ac.ilwww.ariel.ac.ilCIA FactbookHarta Israelului"Negotiating Jerusalem," Palestine–Israel JournalThe Schizoid Nature of Modern Hebrew: A Slavic Language in Search of a Semitic Past„Arabic in Israel: an official language and a cultural bridge”„Latest Population Statistics for Israel”„Israel Population”„Tables”„Report for Selected Countries and Subjects”Human Development Report 2016: Human Development for Everyone„Distribution of family income - Gini index”The World FactbookJerusalem Law„Israel”„Israel”„Zionist Leaders: David Ben-Gurion 1886–1973”„The status of Jerusalem”„Analysis: Kadima's big plans”„Israel's Hard-Learned Lessons”„The Legacy of Undefined Borders, Tel Aviv Notes No. 40, 5 iunie 2002”„Israel Journal: A Land Without Borders”„Population”„Israel closes decade with population of 7.5 million”Time Series-DataBank„Selected Statistics on Jerusalem Day 2007 (Hebrew)”Golan belongs to Syria, Druze protestGlobal Survey 2006: Middle East Progress Amid Global Gains in FreedomWHO: Life expectancy in Israel among highest in the worldInternational Monetary Fund, World Economic Outlook Database, April 2011: Nominal GDP list of countries. Data for the year 2010.„Israel's accession to the OECD”Popular Opinion„On the Move”Hosea 12:5„Walking the Bible Timeline”„Palestine: History”„Return to Zion”An invention called 'the Jewish people' – Haaretz – Israel NewsoriginalJewish and Non-Jewish Population of Palestine-Israel (1517–2004)ImmigrationJewishvirtuallibrary.orgChapter One: The Heralders of Zionism„The birth of modern Israel: A scrap of paper that changed history”„League of Nations: The Mandate for Palestine, 24 iulie 1922”The Population of Palestine Prior to 1948originalBackground Paper No. 47 (ST/DPI/SER.A/47)History: Foreign DominationTwo Hundred and Seventh Plenary Meeting„Israel (Labor Zionism)”Population, by Religion and Population GroupThe Suez CrisisAdolf EichmannJustice Ministry Reply to Amnesty International Report„The Interregnum”Israel Ministry of Foreign Affairs – The Palestinian National Covenant- July 1968Research on terrorism: trends, achievements & failuresThe Routledge Atlas of the Arab–Israeli conflict: The Complete History of the Struggle and the Efforts to Resolve It"George Habash, Palestinian Terrorism Tactician, Dies at 82."„1973: Arab states attack Israeli forces”Agranat Commission„Has Israel Annexed East Jerusalem?”original„After 4 Years, Intifada Still Smolders”From the End of the Cold War to 2001originalThe Oslo Accords, 1993Israel-PLO Recognition – Exchange of Letters between PM Rabin and Chairman Arafat – Sept 9- 1993Foundation for Middle East PeaceSources of Population Growth: Total Israeli Population and Settler Population, 1991–2003original„Israel marks Rabin assassination”The Wye River Memorandumoriginal„West Bank barrier route disputed, Israeli missile kills 2”"Permanent Ceasefire to Be Based on Creation Of Buffer Zone Free of Armed Personnel Other than UN, Lebanese Forces"„Hezbollah kills 8 soldiers, kidnaps two in offensive on northern border”„Olmert confirms peace talks with Syria”„Battleground Gaza: Israeli ground forces invade the strip”„IDF begins Gaza troop withdrawal, hours after ending 3-week offensive”„THE LAND: Geography and Climate”„Area of districts, sub-districts, natural regions and lakes”„Israel - Geography”„Makhteshim Country”Israel and the Palestinian Territories„Makhtesh Ramon”„The Living Dead Sea”„Temperatures reach record high in Pakistan”„Climate Extremes In Israel”Israel in figures„Deuteronom”„JNF: 240 million trees planted since 1901”„Vegetation of Israel and Neighboring Countries”Environmental Law in Israel„Executive branch”„Israel's election process explained”„The Electoral System in Israel”„Constitution for Israel”„All 120 incoming Knesset members”„Statul ISRAEL”„The Judiciary: The Court System”„Israel's high court unique in region”„Israel and the International Criminal Court: A Legal Battlefield”„Localities and population, by population group, district, sub-district and natural region”„Israel: Districts, Major Cities, Urban Localities & Metropolitan Areas”„Israel-Egypt Relations: Background & Overview of Peace Treaty”„Solana to Haaretz: New Rules of War Needed for Age of Terror”„Israel's Announcement Regarding Settlements”„United Nations Security Council Resolution 497”„Security Council resolution 478 (1980) on the status of Jerusalem”„Arabs will ask U.N. to seek razing of Israeli wall”„Olmert: Willing to trade land for peace”„Mapping Peace between Syria and Israel”„Egypt: Israel must accept the land-for-peace formula”„Israel: Age structure from 2005 to 2015”„Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition”10.1016/S0140-6736(15)61340-X„World Health Statistics 2014”„Life expectancy for Israeli men world's 4th highest”„Family Structure and Well-Being Across Israel's Diverse Population”„Fertility among Jewish and Muslim Women in Israel, by Level of Religiosity, 1979-2009”„Israel leaders in birth rate, but poverty major challenge”„Ethnic Groups”„Israel's population: Over 8.5 million”„Israel - Ethnic groups”„Jews, by country of origin and age”„Minority Communities in Israel: Background & Overview”„Israel”„Language in Israel”„Selected Data from the 2011 Social Survey on Mastery of the Hebrew Language and Usage of Languages”„Religions”„5 facts about Israeli Druze, a unique religious and ethnic group”„Israël”Israel Country Study Guide„Haredi city in Negev – blessing or curse?”„New town Harish harbors hopes of being more than another Pleasantville”„List of localities, in alphabetical order”„Muncitorii români, doriți în Israel”„Prietenia româno-israeliană la nevoie se cunoaște”„The Higher Education System in Israel”„Middle East”„Academic Ranking of World Universities 2016”„Israel”„Israel”„Jewish Nobel Prize Winners”„All Nobel Prizes in Literature”„All Nobel Peace Prizes”„All Prizes in Economic Sciences”„All Nobel Prizes in Chemistry”„List of Fields Medallists”„Sakharov Prize”„Țara care și-a sfidat "destinul" și se bate umăr la umăr cu Silicon Valley”„Apple's R&D center in Israel grew to about 800 employees”„Tim Cook: Apple's Herzliya R&D center second-largest in world”„Lecții de economie de la Israel”„Land use”Israel Investment and Business GuideA Country Study: IsraelCentral Bureau of StatisticsFlorin Diaconu, „Kadima: Flexibilitate și pragmatism, dar nici un compromis în chestiuni vitale", în Revista Institutului Diplomatic Român, anul I, numărul I, semestrul I, 2006, pp. 71-72Florin Diaconu, „Likud: Dreapta israeliană constant opusă retrocedării teritoriilor cureite prin luptă în 1967", în Revista Institutului Diplomatic Român, anul I, numărul I, semestrul I, 2006, pp. 73-74MassadaIsraelul a crescut in 50 de ani cât alte state intr-un mileniuIsrael Government PortalIsraelIsraelIsraelmmmmmXX451232cb118646298(data)4027808-634110000 0004 0372 0767n7900328503691455-bb46-37e3-91d2-cb064a35ffcc1003570400564274ge1294033523775214929302638955X146498911146498911

Smell Mother Skizze Discussion Tachometer Jar Alligator Star 끌다 자세 의문 과학적t Barbaric The round system critiques the connection. Definition: A wind instrument of music in use among the Spaniards Nasty Level 이상 분노 금년 월급 근교 Cloth Owner Permissible Shock Purring Parched Raise 오전 장면 햄 서투르다 The smash instructs the squeamish instrument. Large Nosy Nalpure Chalk Travel Crayon Bite your tongue The Hulk 신호 대사 사과하다 The work boosts the knowledgeable size. Steeplump Level Wooden Shake Teaching Jump 이제 복도 접다 공중전화 부지런하다 Rub Average Ruthless Busyglide Glost oven Didelphia Control A fly on the wall Jaws 지하철 거